222 related articles for article (PubMed ID: 27475647)
1. Quantification of Circulating Free DNA as a Diagnostic Marker in Gall Bladder Cancer.
Kumari S; Tewari S; Husain N; Agarwal A; Pandey A; Singhal A; Lohani M
Pathol Oncol Res; 2017 Jan; 23(1):91-97. PubMed ID: 27475647
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Value of Circulating Free DNA Integrity and Global Methylation Status in Gall Bladder Carcinoma.
Kumari S; Husain N; Agarwal A; Neyaz A; Gupta S; Chaturvedi A; Lohani M; Sonkar AA
Pathol Oncol Res; 2019 Jul; 25(3):925-936. PubMed ID: 29376201
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of quantification of circulating free DNA for gall bladder cancer using a chemiluminescence DNA biosensor system based on DNA G-quadruplex/ hemin enzyme.
Ying H; Fengying S; Feng H; Yanhong W; Xianru X; Xiaolei T
Transl Oncol; 2021 Jan; 14(1):100928. PubMed ID: 33212417
[TBL] [Abstract][Full Text] [Related]
4. Comparison of circulating DNA in malignant neoplasia from diverse locations: Investigating a diagnostic role.
Kumari S; Mishra S; Husain N; Verma T; Tiwari V; Kaif M; Agarwal A; Rastogi M; Shukla S; Sonkar AA
Indian J Pathol Microbiol; 2022; 65(1):93-99. PubMed ID: 35074971
[TBL] [Abstract][Full Text] [Related]
5. Fragile histidine triad (FHIT) gene and its association with p53 protein expression in the progression of gall bladder cancer.
Priya TP; Kapoor VK; Krishnani N; Agrawal V; Agarwal S
Cancer Invest; 2009 Aug; 27(7):764-73. PubMed ID: 19452299
[TBL] [Abstract][Full Text] [Related]
6. The diagnostic role of circulating inflammation-based biomarker in gallbladder carcinoma.
Liu XF; Zhou LY; Wei ZH; Liu JX; Li A; Wang XZ; Ying HQ
Biomark Med; 2018 Oct; 12(10):1095-1103. PubMed ID: 30191731
[TBL] [Abstract][Full Text] [Related]
7. Anticipatory extended cholecystectomy: the 'Lucknow' approach for thick walled gall bladder with low suspicion of cancer.
Kapoor VK; Singh R; Behari A; Sharma S; Kumar A; Prakash A; Singh RK; Kumar A; Saxena R
Chin Clin Oncol; 2016 Feb; 5(1):8. PubMed ID: 26932432
[TBL] [Abstract][Full Text] [Related]
8. Circulating cell-free DNA: a promising marker of regional lymphonode metastasis in breast cancer patients.
Agostini M; Enzo MV; Bedin C; Belardinelli V; Goldin E; Del Bianco P; Maschietto E; D'Angelo E; Izzi L; Saccani A; Zavagno G; Nitti D
Cancer Biomark; 2012; 11(2-3):89-98. PubMed ID: 23011155
[TBL] [Abstract][Full Text] [Related]
9. Plasma cell-free DNA level and its integrity as biomarkers to distinguish non-small cell lung cancer from tuberculosis.
Leng S; Zheng J; Jin Y; Zhang H; Zhu Y; Wu J; Xu Y; Zhang P
Clin Chim Acta; 2018 Feb; 477():160-165. PubMed ID: 29113814
[TBL] [Abstract][Full Text] [Related]
10. Xanthogranulomatous cholecystitis: a clinicopathological study of its association with gallbladder carcinoma.
Zhuang PY; Zhu MJ; Wang JD; Zhou XP; Quan ZW; Shen J
J Dig Dis; 2013 Jan; 14(1):45-50. PubMed ID: 23134201
[TBL] [Abstract][Full Text] [Related]
11. Circulating microRNAs in gallbladder cancer: Is serum assay of diagnostic value?
Srivastava P; Mishra S; Agarwal A; Pandey A; Husain N
Pathol Res Pract; 2023 Feb; 242():154320. PubMed ID: 36682281
[TBL] [Abstract][Full Text] [Related]
12. Prognostic relevance of human telomerase reverse transcriptase (hTERT) expression in patients with gall bladder disease and carcinoma.
Deblakshmi RK; Deka M; Saikia AK; Sharma BK; Singh N; Das NN; Bose S
Asian Pac J Cancer Prev; 2015; 16(7):2923-8. PubMed ID: 25854384
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic role of cell-free DNA testing for colorectal cancer patients.
Bedin C; Enzo MV; Del Bianco P; Pucciarelli S; Nitti D; Agostini M
Int J Cancer; 2017 Apr; 140(8):1888-1898. PubMed ID: 27943272
[TBL] [Abstract][Full Text] [Related]
14. Quantification of free circulating DNA as a diagnostic marker in lung cancer.
Sozzi G; Conte D; Leon M; Ciricione R; Roz L; Ratcliffe C; Roz E; Cirenei N; Bellomi M; Pelosi G; Pierotti MA; Pastorino U
J Clin Oncol; 2003 Nov; 21(21):3902-8. PubMed ID: 14507943
[TBL] [Abstract][Full Text] [Related]
15. Aberrant Telomere Length in Circulating Cell-Free DNA as Possible Blood Biomarker with High Diagnostic Performance in Endometrial Cancer.
Benati M; Montagnana M; Danese E; Mazzon M; Paviati E; Garzon S; Laganà AS; Casarin J; Giudici S; Raffaelli R; Ghezzi F; Franchi M; Lippi G
Pathol Oncol Res; 2020 Oct; 26(4):2281-2289. PubMed ID: 32462419
[TBL] [Abstract][Full Text] [Related]
16. Xanthogranulomatous cholecystitis: differentiation from associated gall bladder carcinoma.
Rao RV; Kumar A; Sikora SS; Saxena R; Kapoor VK
Trop Gastroenterol; 2005; 26(1):31-3. PubMed ID: 15974235
[TBL] [Abstract][Full Text] [Related]
17. Serum vascular endothelial growth factors C and D as forecast tools for patients with gallbladder carcinoma.
Liu MC; Jiang L; Hong HJ; Meng ZW; Du Q; Zhou LY; She FF; Chen YL
Tumour Biol; 2015 Aug; 36(8):6305-12. PubMed ID: 25801241
[TBL] [Abstract][Full Text] [Related]
18. Use of a new generation of capillary electrophoresis to quantify circulating free DNA in non-small cell lung cancer.
Chiappetta C; Anile M; Leopizzi M; Venuta F; Della Rocca C
Clin Chim Acta; 2013 Oct; 425():93-6. PubMed ID: 23892142
[TBL] [Abstract][Full Text] [Related]
19. Roles of Salmonella typhi and Salmonella paratyphi in Gallbladder Cancer Development.
Shukla R; Shukla P; Behari A; Khetan D; Chaudhary RK; Tsuchiya Y; Ikoma T; Asai T; Nakamura K; Kapoor VK
Asian Pac J Cancer Prev; 2021 Feb; 22(2):509-516. PubMed ID: 33639667
[TBL] [Abstract][Full Text] [Related]
20. Aberrant reduction of telomere repetitive sequences in plasma cell-free DNA for early breast cancer detection.
Wu X; Tanaka H
Oncotarget; 2015 Oct; 6(30):29795-807. PubMed ID: 26356673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
